Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeremy Pettus

Showing results (1-10 of 47) with videos related to

Pageof 5
Sort By:
Postgraduate Medicine|October 4, 2021
Importance of diabetes management during the COVID-19 pandemicJeremy Pettus, Neil Skolnik
The American Journal of Medicine|October 6, 2014
Challenges associated with insulin therapy in type 2 diabetes mellitusSteven Edelman, Jeremy Pettus
Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy|April 27, 2018
Cardiovascular effects of sodium glucose cotransporter 2 inhibitorsTricia Santos Cavaiola, Jeremy Pettus
Journal of Diabetes Science and Technology|August 18, 2016
Recommendations for Using Real-Time Continuous Glucose Monitoring (rtCGM) Data for Insulin Adjustments in Type 1 DiabetesJeremy Pettus, Steven V Edelman
Diabetes Technology & Therapeutics|January 20, 2016
Use of Glucose Rate of Change Arrows to Adjust Insulin Therapy Among Individuals with Type 1 Diabetes Who Use Continuous Glucose MonitoringJeremy Pettus, Steven V Edelman
Journal of Diabetes Science and Technology|April 6, 2016
Differences in Use of Glucose Rate of Change (ROC) Arrows to Adjust Insulin Therapy Among Individuals With Type 1 and Type 2 Diabetes Who Use Continuous Glucose Monitoring (CGM)Jeremy Pettus, Steven V Edelman
Acta Diabetologica|December 1, 2017
The shifting paradigm of a "cure" for type 1 diabetes: is technology replacing immune-based therapies?Jeremy Pettus, Matthias Von Herrath
Journal of Diabetes Science and Technology|February 18, 2016
Unblinded CGM Should Replace Blinded CGM in the Clinical Management of DiabetesDavid Ahn, Jeremy Pettus, Steven Edelman
Clinical Immunology (Orlando, Fla.)|May 7, 2013
GLP-1 agonists in type 1 diabetesJeremy Pettus, Irl Hirsch, Steven Edelman
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|February 27, 2015
HOW PATIENTS WITH TYPE 1 DIABETES TRANSLATE CONTINUOUS GLUCOSE MONITORING DATA INTO DIABETES MANAGEMENT DECISIONSJeremy Pettus, David A Price, Steven V Edelman
Pageof 5

Showing results (1-10 of 47) with videos related to

Sort By:
Pageof 5
Postgraduate Medicine|October 4, 2021
Importance of diabetes management during the COVID-19 pandemicJeremy Pettus, Neil Skolnik
The American Journal of Medicine|October 6, 2014
Challenges associated with insulin therapy in type 2 diabetes mellitusSteven Edelman, Jeremy Pettus
Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy|April 27, 2018
Cardiovascular effects of sodium glucose cotransporter 2 inhibitorsTricia Santos Cavaiola, Jeremy Pettus
Journal of Diabetes Science and Technology|August 18, 2016
Recommendations for Using Real-Time Continuous Glucose Monitoring (rtCGM) Data for Insulin Adjustments in Type 1 DiabetesJeremy Pettus, Steven V Edelman
Diabetes Technology & Therapeutics|January 20, 2016
Use of Glucose Rate of Change Arrows to Adjust Insulin Therapy Among Individuals with Type 1 Diabetes Who Use Continuous Glucose MonitoringJeremy Pettus, Steven V Edelman
Journal of Diabetes Science and Technology|April 6, 2016
Differences in Use of Glucose Rate of Change (ROC) Arrows to Adjust Insulin Therapy Among Individuals With Type 1 and Type 2 Diabetes Who Use Continuous Glucose Monitoring (CGM)Jeremy Pettus, Steven V Edelman
Acta Diabetologica|December 1, 2017
The shifting paradigm of a "cure" for type 1 diabetes: is technology replacing immune-based therapies?Jeremy Pettus, Matthias Von Herrath
Journal of Diabetes Science and Technology|February 18, 2016
Unblinded CGM Should Replace Blinded CGM in the Clinical Management of DiabetesDavid Ahn, Jeremy Pettus, Steven Edelman
Clinical Immunology (Orlando, Fla.)|May 7, 2013
GLP-1 agonists in type 1 diabetesJeremy Pettus, Irl Hirsch, Steven Edelman
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|February 27, 2015
HOW PATIENTS WITH TYPE 1 DIABETES TRANSLATE CONTINUOUS GLUCOSE MONITORING DATA INTO DIABETES MANAGEMENT DECISIONSJeremy Pettus, David A Price, Steven V Edelman
Pageof 5